Seegene’s High Multiplex PCR Assay Capable of Detecting New Omicron Variant

Published on: PR Newswire The Allplex™ SARS-CoV-2 Master Assay can simultaneously detect the wild-type coronavirus and the Omicron variant in a single test tube Seegene will support countries in need of diagnostics to help slow Omicron’s spread Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today confirmed that its Allplex™ SARS-CoV-2 Master Assay is […]

The SARS CoV-2 Lambda Variant: Here’s What You Should Know

Like all RNA viruses, SARS-CoV-2 is prone to mutations—adaptive changes that can alter a virus’ pathogenic potential and other characteristics. These mutations can create distinct variants of the virus, adding complexity to what has already become the most significant global public health challenge since the 1918 influenza pandemic.    On June 15, 2021, the World Health […]

The Rapid Evolution of Seegene’s COVID-19 Solutions

It’s been one year since Seegene produced a complete respiratory diagnostic test that has taken the uncertainty out of differentiating COVID-19 infection from other respiratory illnesses Fast Response In January 2020, before a single patient with SARS-CoV-2 virus had been identified in South Korea, molecular diagnostic company Seegene leveraged its proven automated assay development platform […]

The Future of Diagnostics: Syndromic Assays

How High Multiplex assays that test for many common pathogens at once can accelerate diagnostics and facilitate a higher quality of care When a patient presents with a symptom, many pathogens could be at fault. Standard clinical practice is to take a sample from the patient and perform a diagnostic test or tests for suspected […]